A guide for drug use in depressive disorders.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001007:Anxiety; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology; D004341:Drug Evaluation; D005260:Female; D006760:Hospitalization; D006791:Hostility; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007099:Imipramine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010624:Phenelzine / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012075:Remission, Spontaneous; D012893:Sleep Wake Disorders / Q000188:drug therapy; D014481:United States; D014482:United States Substance Abuse and Mental Health Services Administration
D010919:Placebos; D010624:Phenelzine; D007099:Imipramine; D003975:Diazepam; D002746:Chlorpromazine